Postoperative Pain Management in Rhinoplasty: A Double Blind Randomized Controlled Trial
- 3 March 2026
- journal article
- Published by SAGE Publications in Facial Plastic Surgery & Aesthetic Medicine
- Vol. 28 (6) , 647-655
Abstract
Background: There is inadequate evidence for the utilization of nonnarcotic pain medications for postoperative pain management following rhinoplasty. Objective: To compare the effectiveness of opioid and non-opioid medications for postoperative pain control in rhinoplasty as measured by a visual analog scale (VAS) on postoperative days 0–5. Methods: In this double-blind randomized controlled clinical trial, adult patients who underwent primary rhinoplasty at a tertiary center were enrolled from August 2019 to October 2024. Patients were randomized to receive either a combination of acetaminophen (325 mg) and hydrocodone (5 mg) or acetaminophen (325 mg) and ibuprofen (200 mg), 1–2 tablets every 4 h for five postoperative days. Tramadol (50 mg) was prescribed for breakthrough pain. Results: A total of 130 patients (65 per group) completed the study. The average age (SD) was 32 (10.7) years. The majority were women (77%), White (68%), and underwent combined functional and aesthetic rhinoplasty (52%). There was no difference detected in mean postoperative pain (VAS) scores recorded on postoperative days 0–5, between treatment groups ( p = 0.156). Among side effects, only itchiness was significantly higher ( p = 0.001) in the hydrocodone–acetaminophen group. Conclusion: This trial demonstrates a lack of difference between opioid and non-opioid pain medications in postoperative pain control after rhinoplasty.Keywords
This publication has 20 references indexed in Scilit:
- Opioid Prescribing Patterns Among Facial Plastic and Reconstructive Surgeons in the Medicare PopulationFacial Plastic Surgery & Aesthetic Medicine, 2021
- Examining Preoperative Expectations and Postoperative Satisfaction in Rhinoplasty Patients: A Single-Center StudyFacial Plastic Surgery & Aesthetic Medicine, 2021
- Assessment of Persistent and Prolonged Postoperative Opioid Use Among Patients Undergoing Plastic and Reconstructive SurgeryJAMA Facial Plastic Surgery, 2019
- Minimal Clinically Important Difference of the Standardized Cosmesis and Health Nasal Outcomes SurveyAesthetic Surgery Journal, 2019
- Postoperative pain and analgesic requirements after septoplasty and rhinoplastyThe Laryngoscope, 2019
- Opioid Prescription Patterns After RhinoplastyJAMA Facial Plastic Surgery, 2019
- The 10-Item Standardized Cosmesis and Health Nasal Outcomes Survey (SCHNOS) for Functional and Cosmetic RhinoplastyJAMA Facial Plastic Surgery, 2018
- Opioid Use by Patients After RhinoplastyJAMA Facial Plastic Surgery, 2018
- Is Ketorolac Safe to Use in Plastic Surgery? A Critical ReviewAesthetic Surgery Journal, 2015
- Measures of adult pain: Visual Analog Scale for Pain (VAS Pain), Numeric Rating Scale for Pain (NRS Pain), McGill Pain Questionnaire (MPQ), Short‐Form McGill Pain Questionnaire (SF‐MPQ), Chronic Pain Grade Scale (CPGS), Short Form‐36 Bodily Pain Scale (SF‐36 BPS), and Measure of Intermittent and Constant Osteoarthritis Pain (ICOAP)Arthritis Care & Research, 2011